Methocarbamol was developed in the early 1950s as a treatment for muscle spasticity and the associated pain. It is a guaiacol glyceryl ether.
...
Methocarbamol tablets and intramuscular injections are indicated in the United States as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. Oral methocarbamol in America may be given up to 1500mg 4 times daily for 2-3 days.
...
Woodland International Research Group, Little Rock, Arkansas, United States
HD Research - Legent Orthopedic Hospital, Carrollton, Texas, United States
Phoenix Clinical Research, Tamarac, Florida, United States
Prisma Health, Greenville, South Carolina, United States
Northwestern University, Chicago, Illinois, United States
Mayo clinic, Rochester, Minnesota, United States
Shinjuku Res. Park Clinic, Tokyo, I.M., Tokyo, Shinjyuku-ku, Japan
Fukuwa Clinic, Tokyo, Chuo-ku, Japan
Tokyo-Eki Center-building Clinic, Tokyo, Chuo-ku, Japan
Montefiore Medical Center, Bronx, New York, United States
Tanta university - faculty of medicine, Tanta, Elgharbia, Egypt
Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.